Beneficial Effects of Oral Carbon Monoxide on Doxorubicin‐Induced Cardiotoxicity

Background Doxorubicin and other anthracyclines are crucial cancer treatment drugs. However, they are associated with significant cardiotoxicity, severely affecting patient care and limiting dosage and usage. Previous studies have shown that low carbon monoxide (CO) concentrations protect against do...

Full description

Bibliographic Details

Published in:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors:	Rodrigo W. Alves de Souza, Vanessa Voltarelli, David Gallo, Sidharth Shankar, Michael S. Tift, Mark Young, Edward Gomperts, Andrew Gomperts, Leo E. Otterbein
Format:	Article
Language:	English
Published:	Wiley 2024-05-01
Subjects:	anthracyclines cancer carbon monoxide cardiotoxicity heme oxygenase‐1
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.123.032067